-
Why EVgo Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Thursday, August 3, 2023 - 8:20am | 841Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares surged 64.6% to $2.19 in pre-market trading. Adamis Pharmaceuticals shares declined around 67% on Wednesday after the company reported pricing of $8 million public offering of 5.93 million units at a price of $1.35 per unit. T2...
-
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Wednesday, August 2, 2023 - 1:07pm | 2164Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. T Stamp Inc. (NASDAQ: IDAI) gained 53.1% to $2.22. Trust Stamp received privacy-secured biometric identification and verification patent....
-
Dynatrace Stock Plunges Despite Upbeat Q1 Performance, Strong Outlook: By The Numbers
Wednesday, August 2, 2023 - 9:38am | 343Dynatrace, Inc (NYSE: DT) reported first-quarter FY24 revenue growth of 25% year-on-year to $332.9 million (CC), beating the consensus of $326.9 million. Annual Recurring Revenue ("ARR") increased 25% Y/Y. Revenues from Subscription rose 27% Y/Y to $316.5 million (CC). The...
-
This Analyst With 86% Accuracy Rate Sees Around 13% Downside In Intel - Here Are 5 Stock Picks For July From Wall Street's Most Accurate Analysts
Tuesday, August 1, 2023 - 7:57am | 755U.S. stocks closed mostly higher on Monday, ending the July month on upbeat quarterly earnings. All three major stock indices recorded gains for July, with the S&P 500 adding 3.1% for the month Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all...
-
This Analyst With 83% Accuracy Rate Sees Around 37% Upside In Alibaba - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Monday, May 22, 2023 - 7:29am | 749U.S. stocks closed lower on Friday after Republicans withdrew from debt ceiling negotiations. However, all three major indices recorded gains last week. Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track...
-
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
Thursday, May 18, 2023 - 8:03am | 540Needham raised the price target for Dynatrace, Inc. (NYSE: DT) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares gained 1.9% to $47.95 in pre-market trading. Maxim Group boosted the price target for Immutep Limited (NASDAQ: IMPP) from $8 to $10. Maxim...
-
Dynatrace Gets Price Target Hikes By Analysts After Upbeat Results
Thursday, May 18, 2023 - 7:33am | 209Dynatrace, Inc (NYSE: DT) reported better-than-expected fourth-quarter results and issued revenue guidance above estimates. Dynatrace reported fourth-quarter FY23 revenue growth of 27% year-on-year to $314.48 million (CC), beating the consensus of $304.96 million. Non-GAAP EPS of $0.31 beat the...
-
"Recession? Nah" - Homebuilders, Probably
Wednesday, May 17, 2023 - 9:56am | 2016The U.S. now spends more money on servicing its debt than national defense. Let that sink in. Market Prices as of 4 pm EST, 5/16/23 Macro US factory output bounced back in April. Industrial and manufacturing production both rose more than expected, increasing by 0.5% and 1%, respectively. The...
-
Dynatrace Shares Are Trading Higher After Q4 Earnings: The Details
Wednesday, May 17, 2023 - 9:11am | 228Dynatrace, Inc (NYSE: DT) reported fourth-quarter FY23 revenue growth of 27% year-on-year to $314.48 million (CC), beating the consensus of $304.96 million. Adjusted ARR increased 29% Y/Y. Revenues from Subscription rose 28% Y/Y to $293 million (CC). Margins: The non-GAAP...
-
Top 5 Tech Stocks That May Fall Off A Cliff
Friday, May 12, 2023 - 7:49am | 654The most overbought stocks in the information technology sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock...
-
Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
Wednesday, February 8, 2023 - 10:18am | 516Loop Capital boosted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $120 to $125. Loop Capital analyst Rob Sanderson maintained a Buy rating. Alphabet shares fell 3.7% to $103.70 in pre-market trading. DA Davidson raised the price target for Microsoft Corporation (NASDAQ: MSFT) from $...
-
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
Wednesday, February 1, 2023 - 11:45am | 540U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Rapid7, Inc. (NASDAQ: RPD) climbed 23.2% to $49.13. Rapid7 is working with Goldman Sachs Group to explore a potential sale, Reuters reported....
-
Dynatrace Clocks 29% Revenue Growth In Q3 Backed By Subscriber Additions; Boosts FY23 Outlook
Wednesday, February 1, 2023 - 9:16am | 265Dynatrace, Inc (NYSE: DT) reported third-quarter FY23 revenue growth of 29% year-on-year to $297.46 million (CC), beating the consensus of $284.70 million. Adjusted ARR increased 29% Y/Y. Revenues from Subscription rose 29% Y/Y to $279.15 million (CC). Margins: The non-GAAP...
-
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
Wednesday, December 7, 2022 - 8:41am | 855Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement. The Very Good Food Company Inc. (NASDAQ: VGFC) shares rose 37% to $0.1096 in pre-market trading after droping 17% on Tuesday. Very...
-
Autoimmune Biotech Scores $26M Payment, Up To $139M To Advance Phase 3 Research
Tuesday, December 6, 2022 - 1:17pm | 393Equillium Inc (NASDAQ: EQ) announced an option and asset purchase agreement through which Ono Pharmaceutical Co Ltd gains the exclusive option to purchase Equillium's rights to itolizumab. These rights include all therapeutic indications and the rights to commercialize...